Navigation Links
3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS
Date:9/12/2012

SHENYANG, China, Sept. 12, 2012 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that its Board of Directors has received a preliminary non-binding proposal letter dated September 12, 2012 from its Chairman and Chief Executive Officer, Dr. Jing Lou, and CPEChina Fund, L.P., an exempted limited partnership registered under the laws of the Cayman Islands and a China-focused private equity fund associated with CITIC Private Equity Funds Management Co. Ltd. ("CITIC PE"), to acquire all of the outstanding shares of 3SBio Inc. not currently owned by Dr. Lou and his affiliates in a going private transaction for $15 per American Depositary Share ("ADS", each ADS representing 7 ordinary shares of the Company) in cash, subject to certain conditions.

According to the proposal letter, the acquisition is intended to be financed through a combination of debt and equity capital, and the buyer consortium has been in discussion with a financial institution which has expressed interest in financing the proposed acquisition.  A copy of the proposal letter is set forth below as Exhibit A.

3SBio's Board of Directors has formed a special committee of independent directors (the "Independent Committee") consisting of Mr. Tianruo (Robert) Pu, Mr. Mingde Yu, and Mr. Peiguo Cong, to consider this proposal. The Independent Committee will retain a financial advisor and legal counsel to assist it in its work. The Board of Directors cautions the Company's shareholders and others considering trading in its securities that the Board just received the preliminary non-binding proposal from Dr. Lou and CITIC PE and no decisions have been made by the Independent Committee with respect to 3SBio's  response to the pro
'/>"/>

SOURCE 3SBio Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. 3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012
2. Apexigen Announces the Filing of an IND by its Partner, 3SBio
3. 3SBio Inc. Announces Changes to Its Board of Directors
4. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
5. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
6. 3SBio Inc. To Present at the DB Access Asia Conference 2012
7. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
8. IncellDx, Inc. Announces an Agreement with BioReference Laboratories, Inc. to Conduct a 10,000 Sample Study Using a Slideless Pap Smear
9. Apexus Announces HRSAs 340B Prime Vendor Contract Renewal
10. NuAire Announces New In-VitroCell Energy Saver CO2 Incubators
11. Thoratec Announces Presentations At Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- It is no secret ... third being overweight or obese gyms and supplement companies are ... the condition is primarily related to dietary issues and a ... the result of a glandular problem or even a vitamin ... common vitamin deficiency is a lack of vitamin b12 ...
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- Today at American ... Christine Ginocchio discussed Specific Technologies ... rapid identification of microorganisms producing bloodstream infection. Dr. ... of the Division of Infectious Disease Diagnostics at ... not-for-profit, non-sectarian health system. (Photo: ...
(Date:5/20/2013)... May 20, 2013  Echo Pharma Acquisition Limited ("Royalty ... Irish Takeover Rules (the "Announcement"), a firm intention to ... ELN ) to $12.50 per share in cash.  ... not conditional on due diligence.  The $1.00 per share ... reserved the right to waive down the Acceptance Threshold ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11
... N.J., May 03, 2007 /PRNewswire-FirstCall/ --,Alpharma ... pharmaceutical company,through its Pharmaceuticals Division, this ... study of its investigational,abuse-deterrent, extended-release opioid ... the American Pain Society in Washington, ...
... /PRNewswire-FirstCall/ --,Genelabs Technologies, Inc. announced today that ... International Conference on Antiviral,Research being held in ... virus (HCV) polymerase inhibitor,discovered by Genelabs. , ... D. Roberts,Ph.D., Director of Medicinal Chemistry at ...
Cached Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3
(Date:5/20/2013)... People are so busy these days, running from ... the roof and are contributing to a number of health ... the difference between life and death. Speakers at the upcoming ... will share valuable, practical tools people can use to boost ... them for social good. , Organised by V Star ...
(Date:5/20/2013)... The Environmental Design Research ... of continuing education credit opportunities for design professionals, ... Architects Continuing Education System (AIA/CES), the Landscape Architecture ... Design Continuing Education Council (IDCEC). EDRA44Providence ... at the Omni Providence Hotel in Providence, Rhode ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Osborn’s ... successor to Anne G. Osborn’s 1993 award winning book ... of the all-time bestselling neuroradiology texts. , In ... special touch to make complex topics visually appealing and ... of brain imaging together with spectacular pathology examples, relevant ...
(Date:5/20/2013)... Huntington,s disease (HD) is currently incurable, the HD ... development may slow or minimize disease progression. ... identification of reliable and sensitive biomarkers to track ... eventually be used as outcome measures in clinical ... changes during the time prior to diagnosis and ...
(Date:5/20/2013)... 20, 2013 National law firm Parker Waichman ... Law Firm P.A., both based in Little Rock, Arkansas – ... proposed $7.25 billion settlement of a price-fixing case against Visa ... was filed Wednesday, May 15, 2013, in the U.S. District ... lawsuit against Visa and MasterCard (Case No. 1:05-md-1720) is titled ...
Breaking Medicine News(10 mins):Health News:Chill Out and Change the World, Say Mind Experts at V Star Bliss Event in Sydney 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2Health News:Osborn’s Brain from Amirsys Publishing Receives Doody’s Top Honors 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3
... sudden cardiac arrest , , MONDAY, Jan. 5 (HealthDay News) -- ... like that. , "I was swimming in a pool at ... was 23 years old and in excellent health, or so ... to a stop face down." , Jim Stoltz,s heart stopped ...
... 5 When Lamont Christian,returned from war, he often felt ... a homeless shelter, a sign that time had not,healed his ... the VA Ann Arbor Healthcare System for help, and there, ... depression, post-,traumatic stress disorder and anger management problems. Now, he ...
... A leader in quality laminate,casework is aiming to become the ... is designed to offer customers guaranteed quicker,delivery. , ... according to Case Systems,President and COO Rick Vander Weele. , ... Vander Weele says. "Regardless of,an order,s size, standard shipping from ...
... Jan. 5 Based on its recent analysis,of ... Toshiba,America Medical Systems with the 2008 North American ... has launched a variety of,cardiovascular imaging devices, including ... line. This product has taken,echocardiography a step ahead ...
... IRVING, Texas, Jan. 5 RBC Life Sciences ... has elected current president, John W. Price, to CEO ... is currently CEO, will remain as chairman of the ... RBC Life Sciences, a global provider of proprietary nutritional ...
... Ensign Group, Inc. (Nasdaq: ENSG ), ... Center, a 150-bed skilled nursing facility in Lufkin, ... The facility has been renamed Southland Rehabilitation & ... a strategic acquisition, and adds to our growing ...
Cached Medicine News:Health News:When the Heart Stops Beating 2Health News:U-M Health Minute: Today's Top Health Issues and Medical Research 2Health News:U-M Health Minute: Today's Top Health Issues and Medical Research 3Health News:CaseQ Quick Ship Casework Program Announced Today 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 3Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 4Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 3Health News:The Ensign Group Acquires Texas Skilled Nursing Facility 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: